ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ET
Company Participants
Al Kildani - SVP, IR and Corporate Communications
Catherine Owen-Adams - CEO
Brendan Teehan - COO, Head of Commercial
Liz Thompson - EVP, Head of Research and Development
Mark Schneyer - CFO
Conference Call Participants
Gregory Renza - RBC Capital Markets
Jason Butler - Citizens JMP
Joe Beatty - Baird
Keith Tapper - BMO Capital Markets
Tazeen Ahmad - Bank of America
Jeff Hung - Morgan Stanley
Charles Duncan - Cantor Fitzgerald
Jay Olson - Oppenheimer
Sumant Kulkarni - Canaccord
Operator
Ladies and gentlemen, thank you for standing by. Welcome to the Third Quarter 2024 ACADIA Pharmaceuticals Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. [Operator Instructions] Please be advised that today's conference is being recorded.
I would like now to turn the conference over to Al Kildani, Senior Vice President, Investor Relations, and Corporate Communications. Please go ahead.
Al Kildani
Thank you. Good afternoon and thank you for joining us on today's call to discuss Acadia's third quarter 2024 earnings results. Joining me on the call today from Acadia are Catherine Owen-Adams, our Chief Executive Officer, who will provide some opening remarks, followed by Brendan Teehan, our Chief Operating Officer and Head of Commercial, who will discuss our strong commercial franchise's DAYBUE and NUPLAZID. Also joining us today is Liz Thompson, Ph.D., Executive Vice President, Head of Research and Development, who will provide an update on our pipeline program, and Mark Schneyer, our Chief Financial Officer, will review the financial results. Catherine will then provide some closing thoughts before we open up the call for your questions.
We are using supplemental slides which are available on our website's events and presentation section.
Before proceeding, I would like to remind you that during our call today, we will make several forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, including goals, expectations, plans, prospects, growth potential, timing of events, future results, and financial guidance, are based on current information, assumptions, and expectations that are inherently subject to change and involve several risks and uncertainties that may cause results to differ materially. These factors and other risks associated with our business can be found in our filings made with the SEC.